Biotechnology & Life Sciences Global On demand · 24-48h

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Strategic Research Report

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Stra…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market
$1.82B2025
4.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Indirect ELISA, Sandwich ELISA, Competitive ELISA, Others

By Application: Laboratory, Testing Institutions, Hospital, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Merck, Bio‑Rad Laboratories, PerkinElmer, Abcam, R&D Systems, BioVendor, Creative Diagnostics, RayBiotech, MyBioSource, Sino Biological, Elabscience, Jianglai Bio

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 106 pages
Market size 2025
$1.82B
Billion USD
Forecast CAGR
4.3%
2025-2032
Forecast 2032
$2.4B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Enzyme-Linked Immunosorbent Assay (ELISA) market size is predicted to grow from US$ 1,818 million in 2025 to US$ 2,430 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032.

ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.

In 2025, global Enzyme-Linked Immunosorbent Assay (ELISA) market reached approximately 1858 Million USD.

The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control. ELISA is a highly sensitive and specific immunoassay used to detect and quantify proteins, hormones, antibodies, and pathogens in biological samples. It plays a critical role in clinical diagnostics for infectious diseases, autoimmune disorders, and cancer biomarkers, as well as in drug development and pharmaceutical research. Its ability to process multiple samples simultaneously, coupled with cost-effectiveness and compatibility with automation, makes ELISA a preferred choice for laboratories worldwide.

Market growth is further fueled by the increasing demand for early disease detection, advancements in immunodiagnostic technologies, and rising investment in life sciences research. The technique is also being adapted for use in point-of-care testing and high-throughput screening, improving its utility across healthcare and biotechnology sectors. However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas. Despite these hurdles, ongoing innovations in assay formats and detection systems ensure that ELISA remains a cornerstone technology in both clinical and research settings.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Enzyme-Linked Immunosorbent Assay (ELISA) market?

What factors are driving Enzyme-Linked Immunosorbent Assay (ELISA) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Enzyme-Linked Immunosorbent Assay (ELISA) market opportunities vary by end market size?

How does Enzyme-Linked Immunosorbent Assay (ELISA) break out by Type, by Application?

This report presents a comprehensive overview of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA
  • Others

Segment by Feature

  • Solid-phase ELISA
  • Liquid-phase ELISA

Segment by Channel

  • Direct Selling
  • Distribution

Segment by Application

  • Laboratory
  • Testing Institutions
  • Hospital
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Enzyme-Linked Immunosorbent Assay (ELISA) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Laboratory, Testing Institutions, Hospital evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.82B
2025
Forecast
$2.4B
2032
CAGR
4.3%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificMerckBio‑Rad LaboratoriesPerkinElmerAbcamR&D SystemsBioVendorCreative Diagnostics
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Indirect ELISASandwich ELISACompetitive ELISAOthers
By Application
LaboratoryTesting InstitutionsHospitalOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Indirect ELISA
  • 3.1.3 Sandwich ELISA
  • 3.1.4 Competitive ELISA
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Laboratory
  • 4.1.3 Testing Institutions
  • 4.1.4 Hospital
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Merck
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Bio‑Rad Laboratories
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 PerkinElmer
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Abcam
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 R&D Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BioVendor
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Creative Diagnostics
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 RayBiotech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 MyBioSource
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Sino Biological
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Elabscience
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Jianglai Bio
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Enzyme-Linked Immunosorbent Assay (ELISA) market size?
The global Enzyme-Linked Immunosorbent Assay (ELISA) market is estimated at US$ 1.82 billion in 2025 (base year) and is projected to reach US$ 2.43 billion by 2032.
What growth rate is expected for the Enzyme-Linked Immunosorbent Assay (ELISA) market through 2032?
The market is expected to grow at a CAGR of 4.3% from 2026 to 2032, expanding from US$ 1.82 billion in 2025 to US$ 2.43 billion in 2032, roughly 1.3 times its base-year value.
How is Enzyme-Linked Immunosorbent Assay (ELISA) defined?
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support.
What are the main segments of the Enzyme-Linked Immunosorbent Assay (ELISA) market by type?
By type, the market is segmented into Indirect ELISA, Sandwich ELISA, Competitive ELISA and Others.
Which applications drive demand in the Enzyme-Linked Immunosorbent Assay (ELISA) market?
Key applications covered include Laboratory, Testing Institutions, Hospital and Others.
Who are the key players in the Enzyme-Linked Immunosorbent Assay (ELISA) market?
Key players profiled include Thermo Fisher Scientific, Merck, Bio‑Rad Laboratories, PerkinElmer, Abcam, R&D Systems, BioVendor and Creative Diagnostics, among 13 companies covered in total.
Which regions and countries are covered for Enzyme-Linked Immunosorbent Assay (ELISA)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Enzyme-Linked Immunosorbent Assay (ELISA) market?
The Enzyme-Linked Immunosorbent Assay (ELISA) market is growing steadily, driven by its wide application in diagnostics, research, and quality control.
What challenges does the Enzyme-Linked Immunosorbent Assay (ELISA) market face?
However, challenges such as the risk of cross-reactivity, the need for skilled personnel, and competition from advanced molecular diagnostic tools like PCR and next-generation sequencing can limit adoption in certain areas.
Who should buy the Enzyme-Linked Immunosorbent Assay (ELISA) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Laboratory, Testing Institutions and Hospital, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Enzyme-Linked Immunosorbent Assay (ELISA) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.